BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16361854)

  • 1. Debate forum: carnitine supplements have not been demonstrated as effective in patients on long-term dialysis therapy.
    Handelman GJ
    Blood Purif; 2006; 24(1):140-2. PubMed ID: 16361854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Debate forum: levocarnitine therapy is rational and justified in selected dialysis patients.
    Schreiber BD
    Blood Purif; 2006; 24(1):128-39. PubMed ID: 16361853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-carnitine supplementation in dialysis patients: does the evidence justify its use?
    Steinman TI
    Semin Dial; 2005; 18(1):1-2. PubMed ID: 15663752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of L-carnitine administration on erythrocyte survival in haemodialysis patients.
    Arduini A; Bonomini M; Clutterbuck EJ; Laffan MA; Pusey CD
    Nephrol Dial Transplant; 2006 Sep; 21(9):2671-2. PubMed ID: 16611680
    [No Abstract]   [Full Text] [Related]  

  • 5. L-carnitine supplementation in dialysis: treatment in quest of disease.
    Wasserstein AG
    Semin Dial; 2013; 26(1):11-5. PubMed ID: 23173999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-carnitine use in dialysis patients: is national coverage for supplementation justified? What were CMS regulators thinking--or were they?
    Steinman TI; Nissenson AR; Glassock RJ; Dickmeyer J; Mattern WD; Parker TF; Hull AR
    Nephrol News Issues; 2003 Apr; 17(5):28-30, 32-4, 36 passim. PubMed ID: 12715624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-carnitine supplementation in the dialysis population: are Australian patients missing out?
    Reuter SE; Faull RJ; Evans AM
    Nephrology (Carlton); 2008 Feb; 13(1):3-16. PubMed ID: 18199095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of oral L-carnitine therapy in chronic hemodialysis patients.
    Sabry AA
    Saudi J Kidney Dis Transpl; 2010 May; 21(3):454-9. PubMed ID: 20427868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [L-carnitine in peritoneal dialysis].
    De Vecchi AF; Arduini A; Di Liberato L; Bonomini M
    G Ital Nefrol; 2011; 28(4):393-400. PubMed ID: 21809308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-Carnitine in the treatment of fatigue in adult celiac disease patients: a pilot study.
    Ciacci C; Peluso G; Iannoni E; Siniscalchi M; Iovino P; Rispo A; Tortora R; Bucci C; Zingone F; Margarucci S; Calvani M
    Dig Liver Dis; 2007 Oct; 39(10):922-8. PubMed ID: 17693145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diastolic dysfunction and pulmonary hypertension in sickle cell anemia: is there a role for L-carnitine treatment?
    El-Beshlawy A; Abd El Raouf E; Mostafa F; Talaat M; Isma'eel H; Aoun E; Hoffbrand AV; Taher A
    Acta Haematol; 2006; 115(1-2):91-6. PubMed ID: 16424656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dialysis-related carnitine disorder.
    Hedayati SS
    Semin Dial; 2006; 19(4):323-8. PubMed ID: 16893411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients.
    Reuter SE; Faull RJ; Ranieri E; Evans AM
    Nephrol Dial Transplant; 2009 Mar; 24(3):990-6. PubMed ID: 18987259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L carnitine in hemodialysis patients.
    Calò LA; Vertolli U; Davis PA; Savica V
    Hemodial Int; 2012 Jul; 16(3):428-34. PubMed ID: 22360675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From anemia trials to clinical practice: understanding the risks and benefits when setting goals for therapy.
    Coyne DW
    Semin Dial; 2008; 21(3):212-6. PubMed ID: 18363603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carnitine and hemodialysis.
    Bellinghieri G; Santoro D; Calvani M; Mallamace A; Savica V
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S116-22. PubMed ID: 12612967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin-resistant refractory renal anemia: effects of oral L-carnitine supplementation.
    Kawabata M; Kasuga S; Hara H; Suyama S; Moriyama K; Takabatake T
    Clin Nephrol; 2001 Mar; 55(3):265-6. PubMed ID: 11316253
    [No Abstract]   [Full Text] [Related]  

  • 18. Dialysis patients treated with Epoetin alfa show improved anemia symptoms: A new analysis of the Canadian Erythropoietin Study Group trial.
    Keown PA; Churchill DN; Poulin-Costello M; Lei L; Gantotti S; Agodoa I; Gitlin M; Gandra SR; Mayne TJ
    Hemodial Int; 2010 Apr; 14(2):168-73. PubMed ID: 20345390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, controlled trial of the effects of adding vitamin B12 and folate to erythropoietin for the treatment of anemia of prematurity.
    Haiden N; Klebermass K; Cardona F; Schwindt J; Berger A; Kohlhauser-Vollmuth C; Jilma B; Pollak A
    Pediatrics; 2006 Jul; 118(1):180-8. PubMed ID: 16818564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.